Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo Open Menu
American Society of Hematology Logo Close
  • ASH Open Menu
    • ASH Home Open External Link
    • ASH Store Open External Link
    • Advocacy Open External Link
    • Education Open External Link
    • Meetings Open External Link
    • Publications Open External Link
    • Research Open External Link
  • ASH Clinical News
  • ASH Image Bank Open External Link
  • ASH News Daily
  • ASH-SAP
  • Blood Journals Open Menu
    • Blood
    • Blood Advances
    • Blood Global Hematology
    • Blood Immunology & Cellular Therapy
    • Blood Neoplasia
    • Blood Red Cells & Iron
    • Blood Vessels, Thrombosis & Hemostasis
  • Hematology
  • The Hematologist
  • International Open Menu
    • Blood Chinese Edition Open External Link
    • Blood Italian Edition Open External Link
    • Blood Latin America Edition Open External Link
    • Blood Spanish Edition Open External Link
Cart
User Tools Dropdown
Cart
Sign In Open Menu
Search Dropdown Menu
header search
    Search
    Blood
    Toggle MenuMenu
    • IssuesOpen Menu
      • Current Issue
      • All Issues
    • First edition
    • AbstractsOpen Menu
      • 2025 Annual Meeting
      • 2025 Late Breaking
      • 2024 Annual Meeting
      • 2024 Late Breaking
      • 2023 Annual Meeting
      • 2023 Late Breaking
      • 2022 Annual Meeting
      • 2022 Late Breaking
      • 2021 Annual Meeting
      • 2020 Annual Meeting
      • 2020 Late Breaking
      • All Meeting Abstracts
    • CollectionsOpen Menu
      • Blood Podcast
      • Blood Cover Contest
      • Maternal Health Compendium Second EditionOpen External Link
      • Maternal Health Compendium First EditionOpen External Link
      • Health Equity CompendiumOpen External Link
      • Blood 70th Anniversary CollectionOpen External Link
      • Multimedia
    • Author CenterOpen Menu
      • Alerts
      • Author Guide
      • Style Guide
      • SubmitOpen External Link
      • Why Submit to Blood?
    • AboutOpen Menu
      • About Blood
      • Alerts
      • Blood ClassifiedsOpen External Link
      • Copyright
      • Editorial Board
      • Publications StaffOpen External Link
      • Public Access
      • Subscriptions
    Skip Nav Destination

    Update search

    Querybuilder input 1
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 2
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 3
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 4
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 5
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI
    Querybuilder input 6
    • Title
    • Author
    • Full Text
    • Abstract
    • Keyword
    • DOI

    NARROW

    Publications

    Filter by publications

    Format

    Filter by format

    Article Type

    Filter by article-type

    Date

    Filter by date
    Apply

    Availability

    Availability
    1-2 of 2
    Toshifumi Fujimori
    Close
    Save search
    Follow your search
    Access your saved searches in your account
    Would you like to receive an alert when new items match your search?
    Close Modal
    Sort by
    Journal Articles

    Impact of prognostic mutations on outcomes with fixed-duration acalabrutinib-venetoclax combinations versus chemoimmunotherapy: An exploratory analysis from AMPLIFY

    Free
    Paolo Ghia, Barbara Eichhorst, Tomasz Wrobel, Inci Alacacıoğlu, Ana Rita da Fonseca, Dennis Carney, Guillaume Cartron, Alina Gerrie, Don Stevens, Marianne de Borja, Toshifumi Fujimori, Ellie John, L. Alex Liggett, Gary De Jesus, Veerendra Munugalavadla, Jennifer Brown
    Journal: Blood
    Blood (2025) 146 (Supplement 1): 3898.
    https://doi.org/10.1182/blood-2025-3898
    Published: 2025
    Journal Articles

    A post hoc safety analysis of fixed-duration acalabrutinib-venetoclax combinations vs chemoimmunotherapy: Results from the phase 3 AMPLIFY trial

    Free
    John Seymour, Andrew Aw, Vincent Ribrag, Guillaume Cartron, Arnon Kater, Ki-Seong Eom, Alan Skarbnik, Alessandra Tedeschi, Malgorzata Wach, Jing-Zhou Hou, Arpad Illes, Batul Suterwala, Jiefen Munley, Ellie John, Toshifumi Fujimori, Jennifer Brown
    Journal: Blood
    Blood (2025) 146 (Supplement 1): 2118.
    https://doi.org/10.1182/blood-2025-2118
    Published: 2025

    Advertisement intended for health care professionals

    Email alerts

    First Edition Alert
    Latest Issue Alert
    Close Modal

    Advertisement intended for health care professionals

    Blood
    • About Blood
    • Abstracts
    • Advertising in Blood
    • Alerts
    • All Issues
    • Author Guide
    • Blood Classifieds
    • Collections
    • Contact Us
    • Current Issue
    • First edition
    • Newsroom
    • Permissions
    • Subscriptions
    • Submit to Blood
    • American Society of Hematology
    • 2021 L Street NW, Suite 900
    • Washington, DC 20036
    • TEL +1 202-776-0544
    • FAX +1 202-776-0545
    American Society of Hematology

    ASH Publications

    • Blood
    • Blood Advances
    • Blood Global Hematology
    • Blood Immunology & Cellular Therapy
    • Blood Neoplasia
    • Blood Red Cells & Iron
    • Blood Vessels, Thrombosis & Hemostasis
    • Hematology, ASH Education Program
    • ASH Clinical News
    • ASH-SAP
    • The Hematologist

    American Society of Hematology

    • ASH Home
    • ASH Image Bank
    • ASH Store

    • Advocacy
    • Education
    • Meetings
    • Research
    Copyright 2025 by American Society of Hematology
     
    • Cookie Settings
    • Privacy Policy
    • Cookie Policy
    • Terms of Use
    • Contact Us
    Close Modal
    Close Modal
    This Feature Is Available To Subscribers Only

    Sign In or Create an Account

    Close Modal
    Close Modal

    Advertisement intended for health care professionals